EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Need for standardization of cytokine profiling in CAR T cell therapy

D Nathan Biery, David P Turicek, Caroline Diorio, Brett A Schroeder, Nirali N Shah

Molecular Therapy · 2024-09 · 32 (9) · 2979-2983

DOI: 10.1016/j.ymthe.2024.03.030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2024-09. Verfasst von D Nathan Biery und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, MD, USA; George Washington University Sc…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Cytokines, Receptors, Chimeric Antigen, Clinical Trials as Topic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, National Institutes of Health, Clinical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With expansion of chimeric antigen receptor (CAR) T cell therapy and broader utilization of anti-cytokine directed therapeutics for toxicity mitigation, the routine assessment of cytokines may enhance understanding of toxicity profiles, guide therapeutic interventions, and facilitate cross-trial comparisons. As specific cytokine elevations can correlate with and provide insights into CAR T cell toxicity, mitigation strategies, and response, we explored the reporting of cytokine detection methods and assessed for the correlation of cytokines to cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) across clinical trials. In this analysis, we reviewed 21 clinical trials across 60 manuscripts that featured a US Food and Drug Administration-approved CAR T cell construct or one of its predecessors. We highlight substantial variability and limited reporting of cytokine measurement platforms and panels used across CAR T cell clinical trials. Specifically, across 60 publications, 28 (46.7%) did not report any cytokine data, representing 6 of 21 (28.6%) clinical trials. In the 15 trials reporting cytokine data, at least 4 different platforms were used. Furthermore, correlation of cytokines with ICANS, CRS, and CRS severity was limited. Considering the fundamental role of cytokines in CAR T cell toxicity, our manuscript supports the need to establish standardization of cytokine measurements as a key biomarker essential to improving outcomes of CAR T cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveCytokinesReceptors, Chimeric AntigenClinical Trials as TopicCytokine Release SyndromeHumansT-LymphocytesNeurotoxicity SyndromesReceptors, Antigen, T-CellBiomarkers

Stichwörter der Autor:innen

CAR T cellT cellsadoptivebiomarkerchimeric antigencytokine release syndromeimmunotherapyneurotoxicitystandardization

Substanzen

CytokinesReceptors, Chimeric AntigenReceptors, Antigen, T-CellBiomarkers

Autor:innen und Institutionen

  • Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, MD, USA; George Washington University School of Medicine, Washington, DC, USA.
  • Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, MD, USA; Division of Biology and Biomedical Sciences, Washington University, St. Louis, MO, USA.
  • Division of Oncology, Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Hematology and Medical Oncology, CCR, NCI, NIH, Bethesda, MD, USA.
  • Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), NIH, Bethesda, MD, USA. Electronic address: nirali.shah@nih.gov.

Förderung

  • Intramural NIH HHS
  • National Institutes of Health
  • Clinical Center
  • National Cancer Institute
  • U.S. Department of Health and Human Services

Zitieren

APA

Biery, D. N., Turicek, D. P., Diorio, C., Schroeder, B. A., & Shah, N. N. (2024). Need for standardization of cytokine profiling in CAR T cell therapy. Molecular Therapy, 32(9), 2979-2983. https://doi.org/10.1016/j.ymthe.2024.03.030

Vancouver

Biery DN, Turicek DP, Diorio C, Schroeder BA, Shah NN. Need for standardization of cytokine profiling in CAR T cell therapy. Molecular Therapy. 2024;32(9):2979-2983. doi:10.1016/j.ymthe.2024.03.030

BibTeX
@article{Biery2024,
  author = {Biery, D Nathan and Turicek, David P and Diorio, Caroline and Schroeder, Brett A and Shah, Nirali N},
  title = {Need for standardization of cytokine profiling in CAR T cell therapy},
  journal = {Molecular Therapy},
  year = {2024},
  volume = {32},
  number = {9},
  pages = {2979--2983},
  doi = {10.1016/j.ymthe.2024.03.030}
}
Kostenlos starten →